Measles, rubella, and mumps titers post chemotherapy plus autologous stem cell transplant in multiple myeloma patients

Am J Hematol. 2022 Feb 1;97(2):E69-E72. doi: 10.1002/ajh.26421. Epub 2021 Dec 1.

Authors

Mariano Arribas¹, Greg J Ahmann¹, Skye Buckner Petty², Esteban Braggio¹, Elitza S Theel³, Rafael Fonseca¹

Affiliations

¹ Department of Hematology/Oncology, Mayo Clinic, Scottsdale, Arizona, USA.
² Division of Health Sciences Research, Mayo Clinic, Scottsdale, Arizona, USA.
³ Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

PMID: 34822201
DOI: 10.1002/ajh.26421

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Antineoplastic Agents / adverse effects
Antineoplastic Agents / therapeutic use
Female
Hematopoietic Stem Cell Transplantation* / adverse effects
Humans
Male
Measles / etiology*
Middle Aged
Multiple Myeloma / therapy*
Mumps / etiology*
Rubella / etiology*
Transplantation, Autologous / adverse effects

Substances

Antineoplastic Agents